These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16933577)

  • 21. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
    Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of infarct size by short-term pretreatment with atorvastatin.
    Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
    Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
    Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study.
    Adel A; Abdel-Salam Z; Nammas W
    J Clin Hypertens (Greenwich); 2010 Oct; 12(10):820-5. PubMed ID: 21029347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
    Nusca A; Melfi R; Patti G; Sciascio GD
    Future Cardiol; 2010 Sep; 6(5):579-89. PubMed ID: 20932108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.
    Stegmayr BG; Brännström M; Bucht S; Crougneau V; Dimeny E; Ekspong A; Eriksson M; Granroth B; Gröntoft KC; Hadimeri H; Holmberg B; Ingman B; Isaksson B; Johansson G; Lindberger K; Lundberg L; Mikaelsson L; Olausson E; Persson B; Stenlund H; Wikdahl AM;
    Scand J Urol Nephrol; 2005; 39(6):489-97. PubMed ID: 18161210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
    Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
    Tang XL; Sanganalmath SK; Sato H; Bi Q; Hunt G; Vincent RJ; Peng Y; Shirk G; Dawn B; Bolli R
    PLoS One; 2011; 6(9):e25320. PubMed ID: 21980426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
    Malik J; Melenovsky V; Wichterle D; Haas T; Simek J; Ceska R; Hradec J
    Cardiovasc Res; 2001 Nov; 52(2):290-8. PubMed ID: 11684077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
    Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention.
    Li W; Fu X; Wang Y; Li X; Yang Z; Wang X; Geng W; Gu X; Hao G; Jiang Y; Fan W; Wu W; Li S
    Cardiology; 2012; 122(3):195-202. PubMed ID: 22854323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.